Lauren Frenz

Previously, Ms. Frenz was Senior Vice President of Corporate Strategy and Finance at Trucode Gene Repair, Inc., after having served in positions of increasing responsibility at Gilead Sciences, Inc., where she led U.S. healthcare provider marketing for GENVOYA, which became the number one prescribed HIV regimen within in its first year of launch.

Frenz also led launch planning, brand strategy, messaging, and tactic development for several other HIV regimens.

Previously, Frenz served in the Commercial Planning group at Gilead leading the development of market insights, long-range forecasting, product positioning, payer value strategies, and global branding in various therapeutic areas.

Earlier in her career, Frenz worked at Leerink, a healthcare investment bank, in their Strategic Advisory Group, devising business development, commercial, and portfolio management strategies for biopharma companies.

She received her AB from Princeton University and MBA from Harvard Business School.